267 related articles for article (PubMed ID: 15079087)
1. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.
Collins BE; Blixt O; DeSieno AR; Bovin N; Marth JD; Paulson JC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6104-9. PubMed ID: 15079087
[TBL] [Abstract][Full Text] [Related]
2. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22.
Collins BE; Blixt O; Bovin NV; Danzer CP; Chui D; Marth JD; Nitschke L; Paulson JC
Glycobiology; 2002 Sep; 12(9):563-71. PubMed ID: 12213789
[TBL] [Abstract][Full Text] [Related]
3. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.
Danzer CP; Collins BE; Blixt O; Paulson JC; Nitschke L
Int Immunol; 2003 Oct; 15(10):1137-47. PubMed ID: 13679384
[TBL] [Abstract][Full Text] [Related]
4. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.
Sjoberg ER; Powell LD; Klein A; Varki A
J Cell Biol; 1994 Jul; 126(2):549-62. PubMed ID: 8034751
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide.
Bakker TR; Piperi C; Davies EA; Merwe PA
Eur J Immunol; 2002 Jul; 32(7):1924-32. PubMed ID: 12115612
[TBL] [Abstract][Full Text] [Related]
6. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
7. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.
Collins BE; Blixt O; Han S; Duong B; Li H; Nathan JK; Bovin N; Paulson JC
J Immunol; 2006 Sep; 177(5):2994-3003. PubMed ID: 16920935
[TBL] [Abstract][Full Text] [Related]
8. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
[TBL] [Abstract][Full Text] [Related]
9. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
Zhang M; Varki A
Glycobiology; 2004 Nov; 14(11):939-49. PubMed ID: 15240561
[TBL] [Abstract][Full Text] [Related]
10. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
12. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
13. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin.
Sgroi D; Varki A; Braesch-Andersen S; Stamenkovic I
J Biol Chem; 1993 Apr; 268(10):7011-8. PubMed ID: 8463234
[TBL] [Abstract][Full Text] [Related]
14. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
15. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
Tedder TF; Tuscano J; Sato S; Kehrl JH
Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
[TBL] [Abstract][Full Text] [Related]
16. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
[TBL] [Abstract][Full Text] [Related]
17. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.
Nitschke L; Floyd H; Ferguson DJ; Crocker PR
J Exp Med; 1999 May; 189(9):1513-8. PubMed ID: 10224292
[TBL] [Abstract][Full Text] [Related]
19. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
Hanasaki K; Powell LD; Varki A
J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
[TBL] [Abstract][Full Text] [Related]
20. A structure-function study of ligand recognition by CD22beta.
van Rossenberg SM; Sliedregt LA; Autar R; Piperi C; Van Der Merwe AP; van Berkel TJ; Kuiper J; Biessen EA
J Biol Chem; 2001 Apr; 276(16):12967-73. PubMed ID: 11152460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
